ArticleSensors (Basel, Switzerland)2026
Benchmarking Modern Deep Learning Models for Electroluminescence-Based Solar Cell Defect Detection.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study proposes a deep learning-based framework for the automated classification of photovoltaic solar cells as defective or normal using electroluminescence (EL) imaging. A balanced dataset containing 20,400 EL images, comprising 10,200 defective and 10,200 normal solar cells, was used for model development and evaluation. To reflect practical inspection requirements, cracked and broken cells were combined into a single defective category, resulting in a binary classification task. The dataset includes both monocrystalline and polycrystalline solar cells, which were analyzed together within a unified classification framework to improve applicability to real-world photovoltaic systems. To ensure a fair and unbiased evaluation, dataset partitioning was performed prior to any preprocessing or augmentation operations, and each image was assigned exclusively to the training, validation, or test subset. Data augmentation was applied only to the training set, eliminating the possibility of data leakage. Four state-of-the-art deep learning architectures, EfficientNet-B2, ConvNeXt-Tiny, MaxViT-T, and ResNet-50, were trained and evaluated under identical experimental conditions using the same preprocessing pipeline, training strategy, and dataset split. Model performance was assessed using accuracy, precision, recall, F1-score, ROC-AUC, confusion matrices, and explainability-based activation and attention heat maps. All evaluated models achieved classification accuracies exceeding 98%, demonstrating strong capability for EL-based defect detection. EfficientNet-B2 achieved the highest numerical performance, reaching 99.31% accuracy, 0.9931 F1-score, and 0.9987 ROC-AUC. MaxViT-T exhibited similarly strong performance with rapid convergence and balanced class-wise metrics, while ConvNeXt-Tiny and ResNet-50 also produced highly reliable results. Heat map visualizations revealed that EfficientNet-B2 and MaxViT-T concentrated their attention more precisely on defect regions such as cracks and fractures, providing visual interpretability in addition to quantitative performance. The results demonstrate that modern deep learning architectures can accurately and reliably detect photovoltaic cell defects from EL images under a unified binary classification framework. Furthermore, explainability techniques enhance the transparency of model predictions, supporting the practical deployment of intelligent inspection systems for photovoltaic manufacturing and maintenance applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.